Cardiac Arrest Treatment Industry 2025 | Device Upgrades & Drug Development Trends

cardiac arrest treatment market size reached US$ 36.18Billion with a rise of US$38.71Billion in 2024 and is expected to reach US$ 74.42Billion by 2033, growing at a CAGR of 7.5%during the forecast period 2025-2033.

DataM Intelligence has published a new research report on "Cardiac Arrest Treatment Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

According to recent data from the WHO and CDC, cardiovascular diseases (CVDs) remain the world's leading cause of death, responsible for an estimated 19.8 million deaths in 2022, or 32% of all global fatalities. Among these, 85% result from heart attacks and strokes. In the United States, around 805,000 people suffer a heart attack each year, including 605,000 first-time and 200,000 recurrent cases, highlighting the critical need for improved prevention and treatment of cardiac arrest and related heart conditions.

Get a Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/cardiac-arrest-treatment-market?kb

Latest M&A Activity

The cardiac arrest treatment market has seen strategic acquisitions of AI-driven emergency response and monitoring technology companies by key industry players such as Medtronic, Abbott, Boston Scientific, and Philips to enhance advanced resuscitation capabilities and remote patient monitoring solutions.​

Investors are focusing on startups with next-generation mechanical circulatory support devices and innovative drug-device combination therapies for improved outcomes in cardiac arrest cases.

Key Highlights

North America leads the cardiac arrest treatment market, accounting for the largest revenue share of 46.5% in 2024.

Asia Pacific is the fastest-growing region, holding a 24.3% market share in 2024.

By drug class, the vasopressors segment dominated the market with the largest revenue share of 30.4% in 2024.

Key Players:

Pfizer Inc., Viatris Inc., Upsher-Smith Laboratories, LLC, McKesson Medical-Surgical Inc., Sanofi, Par Pharmaceutical, Bayer AG, Bristol-Myers Squibb, Janssen Pharmaceuticals, Neon Laboratories, and Amneal Pharmaceuticals LLC,

Key Development:

For example, in March 2025, Oregon Health and Science University completed a Phase 3 clinical trial evaluating the efficacy and safety of early intravenous amiodarone administration in patients suffering from shockable cardiac arrest.

Growth Forecast Projected:

The Global Cardiac Arrest Treatment Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Regulatory Approvals and FDA Updates

FDA Approvals in 2024-2025

Neurescue Device (Neurescue ApS) received CE Mark approval in September 2025 for non-shockable cardiac arrest treatment, a breakthrough addressing 81% of cardiac arrest patients traditionally ineligible for defibrillation. The device employs balloon occlusion and circulatory augmentation during CPR.​

Vutrisiran (AMVUTTRA®) by Alnylam received FDA approval in March 2025 for treatment of cardiomyopathy associated with transthyretin-mediated amyloidosis, reducing cardiovascular death and hospitalizations in affected patients.​

Other notable cardiac treatment FDA approvals in 2025 include novel vasopressors, cooling catheters, and advanced cardiac monitoring technologies supporting improved resuscitation protocols.

Research Process:

Both primary and secondary data sources have been used in the global Cardiac Arrest Treatment Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence With 30% Discount: https://www.datamintelligence.com/buy-now-page?report=cardiac-arrest-treatment-market?kb

Key Segments:

By Drug Class: (Vasopressors, Beta Blockers, Anti-Arrhythmic Drugs, Anticholinergic Drugs, Corticosteroids, Fibrinolytic Drugs and Other)

By Route of Administration: (Intravenous, Oral and Other)

By End User: (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

Regional Analysis for Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Clinical Trials and Innovations
Ongoing trials include novel RNAi therapies, improved mechanical circulatory support devices, and AI-enhanced rhythm analysis systems to accelerate cardiac arrest diagnosis and treatment.​

The 2025 American Heart Association guidelines emphasize systems of care to prevent in-hospital cardiac arrest and facilitate organ donation after cardiac arrest.

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Cardiac Arrest Treatment producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Cardiac Arrest Treatment revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/cardiac-arrest-treatment-market?kb

FAQ's

Q1: How fast is the Cardiac Arrest Treatment Market growing?

A: The Market is on an impressive growth trajectory, expected to expand at a CAGR of 7.5% from 2025 to 2032

Q2: Which regions are dominating the Cardiac Arrest Treatment Market and which are fastest-growing?

A: The Asia-Pacific region accounted for 24.3% of the global cardiac arrest treatment market share in 2024.

Have any Query? Talk to our Expert @ https://www.datamintelligence.com/enquiry/cardiac-arrest-treatment-market?kb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.